Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Analysts see potential in MDMA drug after AtaiBeckley reports improvements in anxiety trial

Analysts see potential in MDMA drug after AtaiBeckley reports improvements in anxiety trial

  • February 26, 2026

The trial was the first to assess R-MDMA in patients with social anxiety disorder, AtaiBeckley CEO Srinivas Rao said in a statement.

Leave A Comment

Fields (*) Mark are Required